JPS55154971A - Pyrimidine compound* its manufacture* pharmaceutic medicine containing same and its therapeutic use - Google Patents

Pyrimidine compound* its manufacture* pharmaceutic medicine containing same and its therapeutic use

Info

Publication number
JPS55154971A
JPS55154971A JP6586380A JP6586380A JPS55154971A JP S55154971 A JPS55154971 A JP S55154971A JP 6586380 A JP6586380 A JP 6586380A JP 6586380 A JP6586380 A JP 6586380A JP S55154971 A JPS55154971 A JP S55154971A
Authority
JP
Japan
Prior art keywords
pharmaceutic
manufacture
therapeutic use
containing same
pyrimidine compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6586380A
Other languages
English (en)
Inventor
Marukuseru Adorian
Aihenbaaga Kuruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS55154971A publication Critical patent/JPS55154971A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP6586380A 1979-05-18 1980-05-17 Pyrimidine compound* its manufacture* pharmaceutic medicine containing same and its therapeutic use Pending JPS55154971A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH466979 1979-05-18

Publications (1)

Publication Number Publication Date
JPS55154971A true JPS55154971A (en) 1980-12-02

Family

ID=4280399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6586380A Pending JPS55154971A (en) 1979-05-18 1980-05-17 Pyrimidine compound* its manufacture* pharmaceutic medicine containing same and its therapeutic use

Country Status (21)

Country Link
EP (1) EP0019811A1 (ja)
JP (1) JPS55154971A (ja)
KR (1) KR830002757A (ja)
AR (1) AR228256A1 (ja)
AU (1) AU5848480A (ja)
DD (1) DD150609A5 (ja)
DK (1) DK214480A (ja)
ES (1) ES8104279A1 (ja)
FI (1) FI801600A (ja)
GB (1) GB2052487B (ja)
GR (1) GR68453B (ja)
IE (1) IE49803B1 (ja)
IL (1) IL60086A (ja)
MA (1) MA18829A1 (ja)
NO (1) NO801469L (ja)
NZ (1) NZ193730A (ja)
OA (1) OA06533A (ja)
PL (1) PL224313A1 (ja)
PT (1) PT71251A (ja)
ZA (1) ZA802909B (ja)
ZW (1) ZW11880A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005520821A (ja) * 2002-03-15 2005-07-14 チバ　スペシャルティ　ケミカルズ　ホールディング　インコーポレーテッド ４−アミノピリミジン及び表面の抗菌処理のためのその使用
JP2014208692A (ja) * 2008-12-09 2014-11-06 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体のモジュレーター
JP2021534256A (ja) * 2018-08-27 2021-12-09 デウン ファーマシューティカル カンパニー リミテッドDaewoong Pharmaceutical Co., Ltd 新規なヘテロサイクリックアミン誘導体およびこれを含む薬学組成物

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507146A (en) * 1982-12-28 1985-03-26 Ciba-Geigy Corporation 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity
DE3829469A1 (de) * 1988-08-31 1990-03-01 Bayer Ag Verfahren zur herstellung von substituierten n-azinyl-n'-sulfonyl-isothioharnstoffen und n-azinyl-iminodithiokohlensaeure-s,s-diester als zwischenprodukte zu ihrer herstellung
CA2269971A1 (en) * 1997-09-03 1999-03-11 Trent Lee Abraham Pyrimidine derivatives
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
JP4922539B2 (ja) 2000-09-15 2012-04-25 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼインヒビターとして有用なピラゾール化合物
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
NZ526470A (en) 2000-12-21 2006-03-31 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
SK9562003A3 (en) * 2001-01-31 2004-04-06 Synaptic Pharma Corp Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
EP1483247B1 (en) 2002-03-13 2009-06-24 Euro-Celtique S.A. Aryl substituted pyrimidines and the use thereof
WO2003078427A1 (en) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazines as inhibitors of protein kinases
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
AU2003257078B2 (en) 2002-08-02 2010-04-01 Vertex Pharmaceuticals Incorporated Pyrazole compositions useful as inhibitors of GSK-3
WO2004072029A2 (en) 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
WO2007022384A2 (en) 2005-08-18 2007-02-22 Vertex Pharmaceuticals Incorporated Pyrazine kinase inhibitors
EP1951715B1 (en) 2005-11-03 2013-09-04 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
ATE457311T1 (de) 2006-11-02 2010-02-15 Vertex Pharma Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
EP2099787B1 (en) 2006-12-19 2010-07-21 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as inhibitors of protein kinases
KR20090120510A (ko) 2007-03-09 2009-11-24 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로서 유용한 아미노피리미딘
CA2679701A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyridines useful as inhibitors of protein kinases
NZ579446A (en) 2007-03-09 2012-02-24 Vertex Pharma Aminopyrimidines useful as inhibitors of protein kinases
AU2008240313A1 (en) 2007-04-13 2008-10-23 Aj Park Aminopyrimidines useful as kinase inhibitors
CN101801959A (zh) 2007-05-02 2010-08-11 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
EP2152694A2 (en) 2007-05-02 2010-02-17 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
AU2008282156B2 (en) 2007-07-31 2014-07-17 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
EP2323622A1 (en) 2008-09-03 2011-05-25 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) * 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005520821A (ja) * 2002-03-15 2005-07-14 チバ　スペシャルティ　ケミカルズ　ホールディング　インコーポレーテッド ４−アミノピリミジン及び表面の抗菌処理のためのその使用
JP2014208692A (ja) * 2008-12-09 2014-11-06 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体のモジュレーター
JP2021534256A (ja) * 2018-08-27 2021-12-09 デウン ファーマシューティカル カンパニー リミテッドDaewoong Pharmaceutical Co., Ltd 新規なヘテロサイクリックアミン誘導体およびこれを含む薬学組成物

Also Published As

Publication number Publication date
ES491514A0 (es) 1981-04-16
FI801600A (fi) 1980-11-19
DK214480A (da) 1980-11-19
OA06533A (fr) 1981-07-31
KR830002757A (ko) 1983-05-30
GB2052487B (en) 1983-05-11
NO801469L (no) 1980-11-19
DD150609A5 (de) 1981-09-09
PL224313A1 (ja) 1981-02-13
GB2052487A (en) 1981-01-28
IL60086A0 (en) 1980-07-31
ES8104279A1 (es) 1981-04-16
EP0019811A1 (de) 1980-12-10
IE801023L (en) 1980-11-18
AU5848480A (en) 1980-11-20
IL60086A (en) 1984-03-30
PT71251A (en) 1980-06-01
IE49803B1 (en) 1985-12-25
GR68453B (ja) 1981-12-30
ZA802909B (en) 1981-05-27
ZW11880A1 (en) 1980-12-17
NZ193730A (en) 1982-12-21
AR228256A1 (es) 1983-02-15
MA18829A1 (fr) 1980-12-31

Similar Documents

Publication Publication Date Title
JPS55154971A (en) Pyrimidine compound* its manufacture* pharmaceutic medicine containing same and its therapeutic use
JPS5446786A (en) Novel 3*4*55trihydroxypiperidine compound* its manufacture and use for medicine
JPS567714A (en) Pharmaceutical medicine
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
PH23005A (en) Heterocyclic compounds and pharmaceutical preparation containing the same
PH15398A (en) Novel excipient and pharmaceutical composition containing the same
JPS549289A (en) Novel dihydropyridazone compound*its preparation and curative agent containing same
JPS5492938A (en) Peptide compound*its manufacture and medicine
JPS55105683A (en) Novel heterotricyclic derivatives*their manufacture*their use as drug and pharmaceutic composition containing them
JPS5663987A (en) Benzodiazepine compound and its use as medicine
JPS5422497A (en) Novel polyether compound* preparation thereof and use as pharmaceutical
JPS53124238A (en) New prostan derivative * preparation thereof and medicine containing same
PH16618A (en) 7beta-aminothiadiazolyl-acetamido-3-cepem-4-carboxylic acid compounds,pharmaceutical preparation containing such compounds and the use of the latter
JPS5646806A (en) Medicinal composition containing paracetamol
PH16253A (en) Dibenzazepine derivatives,pharmaceutical composition containing them and use of the compound
JPS5543098A (en) Nn*11*44aminoo22quinazolinyl**33 or 44piperidyl**lactam*its manufacture* pharmaceutic drug containing it and therapeutic application thereof
JPS5416482A (en) Novel benzylpyrimidine*its preparation and medicine containing same
DE2966178D1 (en) Compounds of the muramyl-peptide type and medicines containing them
ZW15180A1 (en) Aminothiadiazolyl compounds processes for the manufacture thereof and pharmaceutical preparations containing such compounds and the use thereof
JPS5583757A (en) Dihydropyridazinone*its manufacture and therapeutic drug containing it
JPS55113713A (en) Paracetamol contained medical composition
JPS5524172A (en) Benzimidazole*its manufacture and pharmaceutic medicine containing it
JPS5419986A (en) Novel amidinoobenzylpyrimidine*its preparation and medicine containing same
ZW20982A1 (en) Aminooxazolyl compounds processes for their manufacture pharmaceutical preparations containing these compounds and the use of the latter
JPS5618988A (en) Aminothiadiazolyl compound* its manufacture* drug blend containing same and its use